AUGMENT: Lenalidomide plus Rituximab in R/R Follicular Lymphoma

Opinion
Video

Experts review data updates from the AUGMENT trial and discuss potential clinical implications of these study findings.

Recent Videos
CAR T-cell therapy initially developed for mantle cell lymphoma was subsequently assessed in marginal zone lymphoma.
The efficacy of the BOVen regimen in chronic lymphocytic leukemia facilitated its evaluation in patients with mantle cell lymphoma.
Related Content